Peter Hellings
Leuven, 3000, Belgium
Location status: Recruiting
Location contact
Daan Rodiers, MsC
CONTACT
dominique bullens, MD PhD
CONTACT
NCT Number: NCT06129552
During this project, the investigators want to explore in vitro changes in basal cells and the crosstalk with residing immune cells as potential pathogenic mechanisms in CRSwNP vs healthy controls by using surgically resected patient samples.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Leuven, 3000, Belgium
Location status: Recruiting
Daan Rodiers, MsC
CONTACT
dominique bullens, MD PhD
CONTACT
The investigators want to use patient and healthy control samples to study/compare the following aspects in vitro:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conchotomy involves the reduction or removal of hypertrophic nasal turbinates, aesthetic nose surgery is a surgical procedure that aims to enhance the appearance of the nose, while functional endoscopic sinus surgery is a minimally invasive procedure focused on treating sinus conditions by removing obstructions and improving sinus drainage.
Time frame: 12-24 months
Multiple techniques and functional assays will be used to fully investigate the functional differences between epithelial/basal cells isolated from healthy and CRSwNP samples. The differences in barrier composition will be assessed through TEER measurements (Ω × cm2) and FD4 permeability assays (ng/ml). Moreover, barrier composition is investigated by examining differences in membrane markers and junction expression through immunofluorescence and RT-qPCR. Finally, primary isolated cells will be used to assess protein levels through immunostainings, flow cytometry, and Western blots.
Time frame: 9-18 months
To characterize differences in gene expression, or identify specific genes/cell populations that can contribute to CRSwNP, scRNA-sequencing will be performed, as well as bulk RNA sequencing. Depending on these results, specific triggers or receptors that can contribute to CRSwNP will be investigated by stimulation experiments. Besides, the effect on epigenetic imprinting before and after stimulation by performing ATAC-sequencing or DNA methylation profiling will be studied as well.
Time frame: 9-18 months
The interaction between basal and regulatory T cells in relation to homeostasis and regeneration, and how this might change or contribute in/to CRSwNP will be investigated by co-culturing these cells. This will be assessed through the analysis of the supernatants using the Olink platform to investigate cytokines etc. Besides, there will be bulk RNA sequencing to look at changes in gene expression, as well as proliferation and growth assays to see the effect of T cells on basal cells and vice versa. To look at functional changes we can asses different functional assays and techniques (see outcome 1).
Contact information is provided by the study sponsor or research team.
Dominique Bullens, MD, PhD
CONTACT
Peter Hellings, MD, PhD
CONTACT
Universitaire Ziekenhuizen KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07446738
Chronic Rhinosinusitis With Nasal Polyps
Changchun, China
View Trial DetailsNCT06118554
Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis Without Nasal Polyps
Columbus, Ohio, United States
View Trial DetailsNCT03725956
Apnea, Chronic Rhinosinusitis With Nasal Polyps
Lille, France
View Trial DetailsNCT05246267
Chronic Rhinosinusitis With Nasal Polyps
The Bronx, New York, United States
View Trial Details